NIDA - NIDA Community Drug Alert Bulletin - Hepatitis (Chronic Hepatitis C)

NIDA - NIDA Community Drug Alert Bulletin - Hepatitis
for chronic hepatitis C have been effective only in some individuals. The antiviral drug interferon, alone or combined with ribavirin, is approved for treatment of chronic hepatitis C. Researchers are

Research and Clinical Trials: Chronic Hepatitis C + HIV
and Anemia Associated with Pegylated Interferon Plus Ribavirin Treatment of Compensated Chronic Hepatitis C in Adult Subjects Infected with HIV Overview This is a multi-center, randomized, open-labeled

Ribavirin monotherapy for chronic hepatitis C
Chronic hepatitis C is in most cases a benign viral infection, but a minority of patients develop cirrhosis or die. This review shows that ribavirin monotherapy seems without beneficial effects for